Top stories from TTO's August newsletter:
TTO Head David Allen to Direct Tech Launch Arizona
David N. Allen, CU Associate Vice President for Technology Transfer,is leaving the University of Colorado to become the executive director of Tech Launch Arizona (TLA), the new technology commercialization center formed at the University of Arizona.
Now Available: FY2011-12 Performance Overview
Viral Genetics Begins Phase 1 Clinical Trial for Ovarian Cancer
The first patient has now been enrolled into the Phase 1 clinical trial sponsored by CU licensee Viral Genetics and supported by a donation from Scott and White Foundation. The trial will study Metabolic Disruption Technology (MDT) compounds in combination with an existing cancer therapy to treat drug-resistant ovarian cancer.
Read the full newsletter, or sign up to receive a monthly email update.
9 hours ago